• Cell Counting Kit-8 (CCK-8) Plus: Technical Protocol and Bes

  2026-04-25

  Cell Counting Kit-8 (CCK-8) Plus provides researchers with a rapid and sensitive tetrazolium salt assay for quantifying cell proliferation and cytotoxicity across diverse cell types. It is best suited for high-throughput screening, viability assessment, and compound toxicity evaluation where reproducibility and workflow efficiency are critical. This kit is not recommended for direct use in non-enzymatic cellular contexts or tissues incompatible with WST-8 reduction chemistry.

• Cistanche-Derived Nanovesicles Alleviate Sertoli Cell Cycle

  2026-04-24

  This study demonstrates that exosome-like nanovesicles from Cistanche deserticola (CDELNs) target Sertoli cells to alleviate cyclophosphamide-induced testicular injury by reversing cell cycle arrest. The findings offer new mechanistic insight into plant nanovesicle-mediated regulation of the cell cycle and suggest a novel intervention pathway for male reproductive toxicity.

• Nanophotosensitizer Strategy Disables Tumor Extracellular Ve

  2026-04-24

  This study introduces a lipidated nanophotosensitizer that traces and functionally disables tumor extracellular vesicles (TEVs), concurrently inhibiting tumor growth and metastasis in vivo. The approach addresses the longstanding challenge of selectively targeting TEV-mediated communication, offering new avenues for antimetastatic therapy development.

• Sumatriptan Succinate: Advanced Protocols for Migraine Resea

  2026-04-23

  Sumatriptan Succinate is more than a classic migraine research compound—its dual 5-HT1 receptor agonist and anti-inflammatory activities empower robust, reproducible study designs for both acute and mechanistic neurovascular models. Here, we dissect stepwise workflows, highlight recent pediatric emergency department breakthroughs, and deliver actionable troubleshooting for next-generation serotonergic signaling research.

• Gallein: G Protein βγ Subunit Inhibitor for Translational Wo

  2026-04-23

  Gallein, a potent G protein βγ subunit inhibitor from APExBIO, empowers translational researchers to dissect and modulate GPCR signaling. This article delivers detailed workflows, advanced applications, and troubleshooting guidance to maximize data quality in cancer, immunology, and cardiometabolic disease models.

• Meropenem: Ultra-Broad-Spectrum β-Lactam Carbapenem Benchmar

  2026-04-22

  Meropenem is a carbapenem β-lactam antibiotic with ultra-broad-spectrum efficacy against Gram-negative and Gram-positive bacteria. Its superior inhibition of penicillin-binding proteins underpins reliable bactericidal action in resistance modeling. APExBIO’s Meropenem (SKU A5124) demonstrates validated activity and workflow stability for translational research.

• CTCF’s Essential Role in Centromere Function During Mitosis

  2026-04-22

  This study elucidates how the chromatin architectural protein CTCF maintains centromere structure and ensures mitotic fidelity in human cells. Using rapid auxin-inducible degradation, the authors demonstrate that CTCF loss disrupts chromosome alignment and nuclear morphology, revealing a mechanism distinct from CENP-E recruitment and more akin to cohesin function.

• LNP-mRNA Vaccine Targeting C. psittaci: Immune Protection in

  2026-04-21

  This study presents a lipid nanoparticle-encapsulated mRNA vaccine encoding the major outer membrane protein (MOMP) of Chlamydia psittaci. The work demonstrates robust reduction in pathogen load and strong immune responses in mice, providing a substantive foundation for future mRNA vaccine development against respiratory pathogens.

• Vasopressin Analogues: Mechanisms and Multitasking Potential

  2026-04-21

  Glavaš et al. provide a comprehensive review of vasopressin and its analogues, emphasizing structural modifications that enhance pharmacological selectivity, metabolic stability, and clinical applicability. The paper highlights lypressin acetate’s role in antidiuretic therapy and explores emerging evidence for its antiviral and vasopressor uses.

• Butylhydroxyanisole (BHA): Redefining ROS Assays via Precisi

  2026-04-20

  Explore how Butylhydroxyanisole (BHA) elevates oxidative stress research through precise, reproducible ROS modulation. This article reveals advanced protocol insights and reference-driven rationales that set it apart from standard BHA content.

• Necrostatin 2 (Nec-2) for RIPK2 Inhibition in Necroptosis Re

  2026-04-20

  Necrostatin 2 (Nec-2) offers nanomolar precision in dissecting necroptosis, uniquely targeting RIPK2 to unravel programmed necrotic cell death pathways. Its robust performance in ischemic stroke and apoptosis-resistant models makes it indispensable for protocol optimization and troubleshooting in advanced cell death research.

• Repurposing Vitamins as SARS-CoV-2 Inhibitors: Docking Insig

  2026-04-19

  Eskandari (2022) conducted a molecular docking and simulation study to evaluate natural vitamins as inhibitors of both the SARS-CoV-2 main protease (3CLpro) and the spike protein's receptor-binding domain (RBD). The results highlight several vitamins with strong binding affinities at key viral sites, suggesting their potential for repurposing in antiviral therapeutics research and informing the future design of COVID-19 inhibitors.

• Optimizing Erythrocyte Lysis: Red Blood Cell Lysis Buffer in

  2026-04-18

  Selective erythrocyte lysis is the linchpin for high-fidelity blood sample preparation. Here, we explore how APExBIO's Red Blood Cell Lysis Buffer streamlines workflows for flow cytometry, nucleic acid, and protein extraction—delivering reproducibility, robust nucleated cell recovery, and protocol flexibility to drive cutting-edge research.

• VER 155008: HSP 70 Inhibitor for Advanced Cancer Research

  2026-04-17

  VER 155008, a potent adenosine-derived HSP 70 inhibitor, empowers researchers to dissect chaperone-mediated apoptosis and cancer cell proliferation inhibition with precision. This guide translates recent breakthroughs in protein phase separation and chaperone biology into actionable workflows for cancer and neurodegeneration models.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-04-16

  Xiao et al. (2024) elucidate a pathway by which 25-hydroxycholesterol accumulation in tumor-associated macrophages triggers lysosomal AMPK activation, leading to metabolic and functional reprogramming that enhances immunosuppression. Targeting the cholesterol-25-hydroxylase (CH25H) enzyme disrupts this pathway, promoting anti-tumor immunity and improving response to immune checkpoint therapy.

13449 records 1/897 page Next 12345 下5页 Last page